Transcript Hypofractionation in breast cancer at PGIMER, Chandigarh
Hypofractionation in breast cancer
Yadav BS, Sharma SC Assistant Professor, Dept. of Radiotherapy, PGIMER, Chandigarh
Introduction
• • Breast cancer is as sensitive to fraction size as the normal tissues of the breast and underlying rib cage Hypofractionated radiotherapy is an established treatment in patients with breast cancer.
Aim
To see impact of hypofractionated radiotherapy in breast cancer patients. • Cosmetic outcome • Locoregional recurrence • Disease free survival • Overall survival
Materials and methods
Duration: Analysis: Patient No: Mean age: Variables: Jan 1987 to Dec 2007 Retrospective 2756 49 years Age, menopausal status, tumour stage, histology, grade, DRP, ECE, LVI, ER/PR & HER-2 status
Treatment: Median FU
: Radiotherapy, chemotherapy & hormones 64 months
Age Menopausal status
≥40yr 82% <40yr 18%
54 52 50 48 46 44 42
46% Pre 54% Post
Surgery
• • TM+AC: BCS: 2139(83.5) 420(16.5) • Median No. of nodes: 10:11
Pathological
Characteristics N(%) Tumor stage
T1T2 T3T4
Histology
IDC ILC Others
Grade
I&II III Unknown
DRP
Involved Free 1361(53) 1218(47) 2328(90.5) 90(3.5) 151(6) 2022(79) 446(17) 101(4) 291(11) 2278(89)
Nodal status
50 45 40 35 10 5 0 30 25 20 15
44%
N0
39%
N1 & 2
7%
N3
Characteristics LVI
Yes No
ECE
Present Absent
ER
Positive Negative Unknown
PR
Positive Negative Unknown
HER-2
Positive Negative Unknown
N(%)
522(20) 2247(80) 175(7) 2394(93) 1220(47) 414(16) 935(37) 1044(40) 870(33) 955(27) 256(10) 993(38) 1330(52)
Radiotherapy PMRT Intact Breast Machine: Fields:
CW SCF 35Gy/15#/3wks 40Gy/15#/3wks 40Gy/16#/3wks Cobalt/Linac Tangential SCF
Systemic Treatment
Chemotherapy N(%) Yes No Hormones Yes No 1077(42) 1492(58) 1837(70) 722(30)
Results
35 30 25 20 15 10 5 0
RT 7,7 LRR No RT 33
LRR
RT No RT 46
BCS
7 30
Mast
8
Distant metastases
22 38 RT No RT
Cosmesis
45% 40% 35% 30% 25% 20% 15% 10% 5% 0%
38% 42% Excellent Good 17% Fair 3% Bad
LRRFS
93% 70% RT p<0.001
No RT
Overall survival
86% 76% p<0.001
RT No RT
Dose & fractionation
16 14 4 2 0 12 10 8 6
50Gy 40Gy 35Gy
UK Chd
Conclusion
• • Hypofractionation reduces treatment time to half while maintaining cosmesis and control rates equal to conventional fractionation. It will help the radiation centers worldwide to meet the growing need for radiation in breast cancer, particularly in developing countries where resources are limited.